Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-08-05FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for Simponi Aria (golimumab) filed by Janssen Biotech, Inc., resulting in changes to the product lab…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
A completed multi-country post-marketing observational study assessing the maintenance of effectiveness of adalimumab (Humira) in Ankylosing…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) [Phase 3]
Results from a Phase 3, two-part 26-week study evaluating Etoricoxib for Ankylosing Spondylitis have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs [Phase 3]
Phase 3 trial assessing the response to etoricoxib in ankylosing spondylitis patients with inadequate response to at least two NSAIDs has co…
-
FDA approval · 2015-06-09FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' Original Application for celecoxib, enabling a generic version of Celecoxib to enter the market.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)
This clinical trial update documents basic documentation for adalimumab (Humira) in patients with Ankylosing Spondylitis. The trial results …
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Clinical Trial of Osteoporosis in Ankylosing Spondylitis
This document provides an update on a completed clinical trial studying osteoporosis in individuals with ankylosing spondylitis.
-
FDA approval · 2015-05-28FDA Approved: SULINDAC — Supplemental Application (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
The FDA approved a supplemental application for sulindac from PuraCap Laboratories dba Blu Pharmaceuticals, updating the product’s labeling …
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis [Phase 2]
Phase 2 clinical trial update examining anti-TNF therapy in Ankylosing Spondylitis. The current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem [Phase 4]
Phase 4 clinical trial comparing metal-on-metal hip components with highly crosslinked polyethylene components was terminated. Sponsor: Nova…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
Pfizer conducted a clinical trial evaluating etanercept for ankylosing spondylitis. The study is completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease [NA]
A completed clinical trial evaluated the effect of rosuvastatin on carotid artery plaques in patients with inflammatory joint diseases, incl…
-
CLINICAL_TRIALS withdrawal · 2015-04-30Clinical Trial Update: Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) [Phase 4]
The Phase 4 clinical trial evaluating early treatment with infliximab for hip arthritis associated with ankylosing spondylitis has been with…
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector [EARLY_Phase 1]
The completed early-phase trial evaluated the design, functionality, and ergonomic features of an autoinjector intended for use in rheumatoi…
-
FDA approval · 2015-03-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept), expanding its label with additional indications. The submission status indi…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis [Phase 3]
Phase 3 clinical trial update for apremilast in active ankylosing spondylitis has completed with posted results.
-
CLINICAL_TRIALS research · 2015-03-10Clinical Trial Update: Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns
A completed descriptive clinical trial evaluating Vimovo (naproxen/esomeprazole) in patients with osteoarthritis, rheumatoid arthritis, and …
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis [NA]
The document reports the completion of a basic molecular study aimed at early warning of new pathogenic risk related to Ankylosing Spondylit…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Effect of Exercise on Disease Activity and Cardiovascular Risk Factors in Patients With Ankylosing Spondylitis [NA]
A completed clinical trial evaluating the effect of an exercise program on disease activity and cardiovascular risk factors in patients with…
-
FDA approval · 2015-01-21FDA Approved: COSENTYX — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved the original Biologics License Application for Cosentyx (secukinumab) from Novartis Pharmaceuticals Corporation, establishing i…
-
FDA approval · 2014-12-19FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006) [Phase 3]
Phase 3 trial evaluating golimumab in adults with active axial spondyloarthritis, including ankylosing spondylitis; results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
This clinical trial update reports work productivity outcomes in patients with active ankylosing spondylitis treated with Enbrel (etanercept…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression [Phase 4]
This Phase 4 trial assesses the combination of a TNF inhibitor with pamidronate in ankylosing spondylitis to evaluate effects on radiographi…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
A completed clinical study investigated genetic factors associated with response to anti-TNF therapy in patients with early Ankylosing Spond…